Metallic Particles in APIs, Complaint In
The USFDA issued a Warning letter to Hikal’s API facility in Jigani, Bangalore, India. The
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
